Physician profile
Jeff S Burg
NPI 1033123617
$168,209.57
in general payments reported to CMS, 2019-2025
12 companies · $166K in 2025
The $166K reported for 2025 was more than what 99% of Pediatric Dentistry providers received nationally (typical 2025 total: $42.86).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,511 · 2020: $12.22 · 2021: $16.80 · 2022: $193 · 2023: $89.98 · 2025: $166K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $166K · Food and Beverage: $142.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $166,334.06 |
| Food and Beverage | $142.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tendyne Holdings, INC. | $166,334.06 | 2025 | |
| B2d Marketing | $999.00 | 2019 | |
| A-Dec, INC. | $490.00 | 2019 | |
| Kerr Corporation | $123.51 | 2019-2023 | Accessories |
| Straumann USA LLC | $75.06 | 2022 | |
| Envista Holdings Corporation | $52.40 | 2025 | Spark |
| Nobel Biocare USA | $31.99 | 2023 | Nobelactive |
| Dentsply Sirona INC | $28.44 | 2022 | |
| Ormco Corporation | $26.79 | 2020-2023 | Spark |
| Dmg America LLC | $26.00 | 2023 | |
| Gc America INC. | $16.80 | 2021 | |
| Biolase, INC. | $5.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Burg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.